Biomarker

In this video, Thomas Waddington, MD, assistant clinical professor in the department of medicine, division of pulmonary and critical care medicine at City of Hope National Medical Center, speaks with Healio about what pulmonologists should know about lung cancer mutations.

Quanterix Corp. announced the validation of a laboratory-developed test to quantitatively measure phospho-Tau 181 concentration in plasma to aid in the diagnosis of Alzheimer’s disease.

Researchers have developed a risk prediction model for clinical outcomes in HF with preserved ejection fraction, now including N-terminal pro-B-type natriuretic peptide and high-sensitivity cardiac troponin.

Plasma p-tau217 proved an accurate blood-based biomarker of both tau and amyloid-beta pathological brain alterations for those with Down syndrome and may be used alone or with age as a covariate, per a study published in JAMA Neurology.

In this video, Christine M. Walko, PharmD, BCOP, FCCP, discussed the importance of biomarker testing and the challenges involved.

In this video, Robert Vonderheide, MD, DPhil, discussed the results of the phase 2 randomized study of chemoimmunotherapy for patients with metastatic pancreatic cancer.

Urinary cadmium, copper and zinc may be biomarkers for early detection of AKI, according to data published in Kidney International Reports.

French mental health diagnostics company Alcediag announced the results of a study that identified six blood biomarkers as major hallmarks of bipolar disorder.

Although the development and use of biomarkers in liver transplantation has progressed in recent years, challenges and limitations remain, according to presenters at the American Transplant Congress 2022.

Presence of axonal phosphorylated transactive response DNA-binding protein 43, or pTDP-43, accumulation in intramuscular nerve bundles is a likely biomarker for patients diagnosed with ALS, according to a study published in JAMA Neurology.